qs_id,statement_number,statement
QS12,1,People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit.
QS12,2,People with biopsy-proven invasive breast cancer or ductal carcinoma in situ (DCIS) are not offered a preoperative MRI scan unless there are specific clinical indications for its use.
QS12,3,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling."
QS12,4,People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed.
QS12,5,People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.
QS12,6,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker."
